Botanical species · safety record

Artemisia verlotiorum

The EFSA Compendium of Botanicals holds 14 constituent measurements and 1 genotoxicity assay for Artemisia verlotiorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia verlotiorum Lamotte

14Constituent measurements

1Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Aerial part of plants	Essential oil	≤ 31.6 Percent	GC-MS	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	≥ 12.8 Percent	GC-MS	Resolve DOI
Alpha-thujone	Aerial part of plants	Essential oil	≤ 8 Percent	GC-MS	Resolve DOI
Alpha-thujone	Aerial part of plants	Essential oil	≥ 2.3 Percent	GC-MS	Resolve DOI
Beta-thujone	Aerial part of plants	Essential oil	≤ 14.7 Percent	GC-MS	Resolve DOI
Beta-thujone	Aerial part of plants	Essential oil	≥ 8.3 Percent	GC-MS	Resolve DOI
Camphor	Aerial part of plants	Essential oil	≤ 8.3 Percent	GC-MS	Resolve DOI
Camphor	Aerial part of plants	Essential oil	≥ 3.6 Percent	GC-MS	Resolve DOI
Sesquiterpene alkaloids	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
1,8-cineole	Leaves	Essential oil	21 Percent	GC-MS	No resolvable identifier
Alpha-thujone	Leaves	Essential oil	47 Percent	GC-MS	No resolvable identifier
Beta-thujone	Leaves	Essential oil	10 Percent	GC-MS	No resolvable identifier
Camphor	Leaves	Essential oil	1 Percent	GC-MS	No resolvable identifier
Carvone	Aerial part of plants	Essential oil	1 Percent	GC-MS	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	chromosome aberration	chromosome aberration assay	Other	—	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Vernin, GA. GC/MS analysis of Artemisia verlotiorum Lamotte oil. Journal of essential oil research, 2000, vol. 12, no. 2, p. 143-146.
de Souza, L.F.B., Laughinghouse IV, H.D., Pastori, T., Tedesco, M., Kuhn, A.W., do Canto-Dorow, T.S., Tedesco, S.B. Genotoxic potential of aqueous extracts of Artemisia verlotorum on the cell cycle of Allium cepa. International Journal of Environmental Studies, 2010, vol. 67, no. 6, p. 871-877. DOI
Geissman, Theodore A. Sesquiterpene lactones of Artemisia. Artemisia verlotorum and Artemisia vulgaris.. Phytochemistry (Elsevier), 1970, vol. 9, no. 11, p. 2377-81. DOI
Juteau, F., Masotti, V., Viano, J., Bessiere, JM. Chemical variation in the oil of Artemisia verlotiorum Lamotte of French origin harvested at a vegetative stage and during flowering . Journal of essential oil research, 2005, vol. 17, no. 3, p. 254-256.
Chericoni, S., Flamini, G., Campeol, E., Cioni, PL., Morelli, I. GC-MS analyses of the essential oil from the aerial parts of Artemisia verlotiorum: variability during the year . Biochemical systematics and ecology, 2004, vol. 32, no. 4, p. 423-429. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature